MedTrace Logo

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction

NCT02501005 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2019-07-08

No results posted yet for this study

Summary

The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart failure or symptomatic ventricular tachycardia/ventricular fibrillation (VF) when compared to VT ablation after the third appropriate implantable cardioverter-defibrillator (ICD) shock.

Conditions

  • Ventricular Tachycardia

Interventions

PROCEDURE

VT ablation

Catheter ablation of ventricular tachycardia

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Karl-Heinz Kuck, Prof. · Asklepios Klinik St. Georg, Hamburg (Germany)

  • Stephan Willems, Prof. · Universitäres Herzzentrum, Hamburg (Germany)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-20
Primary Completion
2018-07-20
Completion
2018-07-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501005 on ClinicalTrials.gov